Pharmacokinetic evaluation of roxithromycin and ciprofloxacin in treating complicated avian mycoplasmosis in broiler chickens

R D SINGH; K MODY; H B PATEL; V N SARVAIYA; B R PATEL

doi:10.56093/ijans.v90i10.111253

Authors

R D SINGH Department of Veterinary Science and Animal Husbandry, College of Veterinary Science and Animal Husbandry, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, Gujarat
K MODY R&D Centre, Torrent Pharmaceuticals, Ahmedabad, Gujarat
H B PATEL Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, Gujarat 385 506 India
V N SARVAIYA Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, Gujarat 385 506 India
B R PATEL Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, Gujarat 385 506 India

https://doi.org/10.56093/ijans.v90i10.111253

Keywords:

Broiler chickens, Ciprofloxacin, Complicated avian mycoplasmosis, Pharmacokinetic interaction, Roxithromycin

Abstract

The use of roxithromycin along with ciprofloxacin is having potential to be a promising antimicrobial therapy to treat complicated avian mycoplasmosis in broiler chickens. The present research was undertaken to study the influence of roxithromycin (20 mg/kg body weight) and ciprofloxacin (10 mg/kg body weight) on the oral pharmacokinetics of each other, when both drugs are concomitantly administered in eight healthy male broiler chickens (n=8) and to establish their therapeutic dosage regimens. Their plasma concentrations were assayed by validated ultra high performance liquid chromatography (UHPLC) methods using UV detector. Oral pharmacokinetic parameters were calculated from plasma concentration versus time data based on non-compartmental analysis. Statistically, plasma roxithromycin concentration was significantly higher at one time point only (0.5 h) and plasma ciprofloxacin concentration was significantly lower at the time point of 2 h only when used in combination, in comparison to their respective values obtained after their alone administrations. The pharmacokinetic parameters of roxithromycin and ciprofloxacin showed no significant effect on values of either drug when given in combination and there was a lack of pharmacokinetic interaction between the two antimicrobials. The predicted effective oral dose rate of roxithromycin was 20 mg/kg body weight, every 12 h, and that of ciprofloxacin was 10 mg/kg body weight, every 24 h, to treat complicated avian mycoplasmosis in broiler chickens.

Downloads

Download data is not yet available.

References

Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections. Current Opinion in Infectious Diseases 14(2): 165– 72. DOI: https://doi.org/10.1097/00001432-200104000-00010

Atta A H and Sharif L. 1997. Pharmacokinetics of ciprofloxacin following intravenous and oral administration in broiler chickens. Journal of Veterinary Pharmacology and Therapeutics 20(4): 326–29. DOI: https://doi.org/10.1046/j.1365-2885.1997.00065.x

Awadallah H, Awidat S and El-Mahmoudy A. 2016. Pharmacokinetics of clarithromycin after single intravenous and intracrop bolus administrations to broiler chickens. International Journal of Pharmacology and Toxicology 4(1): 12–18. DOI: https://doi.org/10.14419/ijpt.v4i1.5846

Boothe D M. 2016. MSD Veterinary Manual. Eleventh edition. Merck and Co., Inc., New Jersey, USA.

DAHD. 2017. National Action Plan for egg and poultry-2022 for doubling farmers’ income by 2022. Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture and Farmers Welfare, Government of India, Krishi Bhawan, New Delhi.

De Jong A, Stephan B and Silley P. 2012. Fluoroquinolone resistance of Escherichia coli and Salmonella from healthy livestock and poultry in the EU. Journal of Applied Microbiology 112(2): 239–45. DOI: https://doi.org/10.1111/j.1365-2672.2011.05193.x

Gaynor M and Mankin A S. 2003. Macrolide antibiotics: Binding site, mechanism of action, resistance. Current Topics in Medicinal Chemistry 3: 949–61. DOI: https://doi.org/10.2174/1568026033452159

Goudah A, Abo E S K and Abd E A A. 2004. Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration. Deutsche Tierärztliche Wochenschrift 111: 162–65.

Hannan P C T. 2000. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. Veterinary Research 31(4): 373–95. DOI: https://doi.org/10.1051/vetres:2000100

Ivanova S, Dimitrova D and Petrichev M. 2017. Pharmacokinetics of ciprofloxacin in broiler chickens after single intravenous and intraingluvial administration. Macedonian Veterinary Review 40(1): 67–72. DOI: https://doi.org/10.1515/macvetrev-2017-0013

Jambhekar S S and Breen P J. 2012. Extravascular routes of drug administration. Basic Pharmacokinetics, Second edition. Pp.106–126. Pharmaceutical Press, UK.

Kwon J H. 2017. Macrolides, Ketolides, Lincosamides and Streptogramins. Infectious Diseases, Fourth Edition. pp. 1217– 1229. (Eds) Cohen J, Powderly W G and Opal S M. Elsevier Health Sciences, USA. DOI: https://doi.org/10.1016/B978-0-7020-6285-8.00141-6

Landoni M F and Albarellos G. 2015. The use of antimicrobial agents in broiler chickens. Veterinary Journal 205(1): 21–27. DOI: https://doi.org/10.1016/j.tvjl.2015.04.016

Lavy E, Ziv G, Shem Tov M and Glickman A. 1995. Minimal inhibitory concentrations for canine isolates and oral absorption of roxithromycin in fed and fasted dogs. Journal of Veterinary Pharmacology and Therapeutics 18(5): 382–84. DOI: https://doi.org/10.1111/j.1365-2885.1995.tb00609.x

Ley D H. 2003. Mycoplasma gallisepticum infection. Diseases of Poultry. pp. 722–744. (Eds) Saif Y M, Barnes J J, Fradley A M, Glisson J R, Mc Dangald L R and Swaine D E. Blackwell Publishing, USA.

Lim J H, Park B K and Yun H I. 2006. Pharmacokinetic/ pharmacodynamic modelling of roxithromycin for the inhibitory effect of tumour necrosis factor alpha and interleukin 6 production in dogs. Journal of Veterinary Medicine Series A 53(8): 394–98. DOI: https://doi.org/10.1111/j.1439-0442.2006.00852.x

MacGowan A and Bowker K. 2002. Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models. International Journal of Antimicrobial Agents 19(4): 291–98. DOI: https://doi.org/10.1016/S0924-8579(02)00027-4

Markham A and Faulds D. 1994. Roxithromycin: An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 48(2): 297–326. DOI: https://doi.org/10.2165/00003495-199448020-00011

Papich M G. 2018. Fluoroquinolone antimicrobial drugs. Veterinary Pharmacology and Therapeutics, Tenth edition. pp. 953–987. (Eds) Riviere J E and Papich M G. John Wiley and Sons Inc., USA.

Sikri V, Pal D, Jain R, Kalyani D and Mitra A K. 2004. Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux. American Journal of Therapeutics 11(6): 433–42. DOI: https://doi.org/10.1097/01.mjt.0000132643.69143.64

Singh R D, Mody S K, Patel H B, Sarvaiya V N, Patel B R and Gondaliya S B. 2019. Development and validation of ultra high performance liquid chromatographic (UHPLC) method for the determination of roxithromycin in the broiler plasma. Journal of Pharmaceutical Research International 31(6): 1– 8. DOI: https://doi.org/10.9734/jpri/2019/v31i630318

Sivaseelan S and Balasubramaniam G A. 2013. Predisposing effect of E. coli to Mycoplasma gallisepticum infection in layer chicken. Shanlax International Journal of Veterinary Science 1(1): 1–3.

Sivaseelan S, Malmarugan S, Balachandran P and Balasubramaniam G A. 2013. Synergistic pathological effect of Mycoplasma gallisepticum with other infectious organisms in layer chickens. Brazilian Journal of Veterinary Pathology 6(2): 44–47.

Toutain P L and Lees P. 2004. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 27(6): 467–77. DOI: https://doi.org/10.1111/j.1365-2885.2004.00613.x

Toutain P L, Del Castillo J R and Bousquet-Melou A. 2002. The pharmacokinetic—pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science 73(2): 105–14. DOI: https://doi.org/10.1016/S0034-5288(02)00039-5

Turnidge J D. 1998. The pharmacodynamics of beta-lactams. Clinical Infectious Diseases 27: 10–22. DOI: https://doi.org/10.1086/514622

USDA. 2018. Livestock and Poultry: World Markets and Trade. United States Department of Agriculture, Foreign Agricultural Service. Available at https://apps.fas.usda.gov/psdonline/ circulars/livestock_poultry.pdf accessed on 10th April, 2018.

Vella J, Busuttil F, Bartolo N S, Sammut C, Ferrito V, Serracino- Inglott A, Azzopardi L M and LaFerla G. 2015. A simple HPLC–UV method for the determination of ciprofloxacin in human plasma. Journal of Chromatography B 989: 80–85. DOI: https://doi.org/10.1016/j.jchromb.2015.01.006

Wimer S M, Schoonover L and Garrison M W. 1998. Levofloxacin: a therapeutic review. Clinical Therapeutics 20(6): 1049–70. DOI: https://doi.org/10.1016/S0149-2918(98)80104-5

Zhang Y, Huo M, Zhou J and Xie S. 2010. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs in Biomedicine 99: 306–14. DOI: https://doi.org/10.1016/j.cmpb.2010.01.007